1. Impact of pre-sarcopenia in sorafenib treatment for advanced hepatocellular carcinoma
   Hitomi Takada et al, 2018, PLOS ONE CrossRef
2. Oral chemotherapy for the treatment of hepatocellular carcinoma
   Shun Yamamoto et al, 2018, Expert Opinion on Pharmacotherapy CrossRef
3. Effect of sorafenib starting dose and dose intensity on survival in patients with hepatocellular carcinoma: Results from a Canadian Multicenter Database
   Mohammed A. Alghamdi et al, 2020, Cancer Medicine CrossRef
4. Efficient multiple treatments including molecular targeting agents in a case of recurrent hepatocellular carcinoma, post-living donor liver transplantation
   Reimi Suzuki et al, 2022, Clinical Journal of Gastroenterology CrossRef
5. Real-World Single-Center Clinical Data on Sorafenib in Patients with Unresectable Hepatocellular Carcinoma
   null null et al, 2022, Journal of Medical and Radiation Oncology CrossRef
6. Safety and effectiveness of sorafenib in Japanese patients with hepatocellular carcinoma in daily medical practice: interim analysis of a prospective postmarketing all-patient surveillance study
   Shuichi Kaneko et al, 2016, Journal of Gastroenterology CrossRef
7. First- and Second-Line Targeted Systemic Therapy in Hepatocellular Carcinoma—An Update on Patient Selection and Response Evaluation
   Johann von Felden et al, 2016, Diagnostics CrossRef
8. Dosing, efficacy and safety of lenvatinb in the real‐world treatment of hepatocellular carcinoma: Results from a Canadian database
   Carla Pires Amaro et al, 2022, Liver Cancer International CrossRef
9. Multicenter retrospective study of initial treatment outcome and feasibility of initiating dose reduction of cabozantinib in unresectable hepatocellular carcinoma
   Tetsu Tomonari et al, 2023, Hepatology Research CrossRef
10. The Impact of Sorafenib in Combination with Intermittent Hepatic Arterial Infusion Chemotherapy for Unresectable Hepatocellular Carcinoma with Major Vascular Invasion
    Masaki Kaibori et al, 2022, Cancer Investigation CrossRef
11. Increased cumulative doses and appearance of hand‐foot skin reaction prolonged progression free survival in sorafenib‐treated advanced hepatocellular carcinoma patients
    Wen‐Tsan Chang et al, 2018, The Kaohsiung Journal of Medical Sciences CrossRef
12. Impact of albumin–bilirubin grade on survival in patients with hepatocellular carcinoma who received sorafenib: An analysis using time‐dependent receiver operating characteristic
    Toshifumi Tada et al, 2019, Journal of Gastroenterology and Hepatology CrossRef
13. Advanced hepatocellular carcinoma with remarkable response to sorafenib dose increment: A case report
    Kazuya Anzai et al, 2017, Kanzo CrossRef
14. The effects of low-dose sorafenib on epithelial-mesenchymal transition and multidrug resistance markers in HepG2 cell line
    Yaprak DÖNMEZ ÇAKIL et al, 2023, The European Research Journal CrossRef
15. A case of hepatocellular carcinoma with iliac metastasis achieving complete long-term remission by multidisciplinary therapy with radiation therapy, transcatheter arterial chemoembolization, and sorafenib
    Shunichi Wakabayashi et al, 2018, Kanzo CrossRef
16. Important Clinical Factors in Sequential Therapy Including Lenvatinib against Unresectable Hepatocellular Carcinoma
    Atsushi Hiraoka et al, 2019, Oncology CrossRef
17. ACK1 promotes hepatocellular carcinoma progression via downregulating WWOX and activating AKT signaling
    BINHUI XIE et al, 2015, International Journal of Oncology CrossRef
18. Chemotherapy for Hepatocellular Carcinoma: Current Evidence and Future Perspectives
    Emanuele Rinninella et al, 2017, Journal of Clinical and Translational Hepatology CrossRef
19. Clinical Outcomes of Cabozantinib in Patients Previously Treated with Atezolizumab/Bevacizumab for Advanced Hepatocellular Carcinoma—Importance of Good Liver Function and Good Performance Status
    Teiji Kuzuya et al, 2023, Cancers CrossRef
20. Comparison of five staging systems in hepatocellular carcinoma treated with sorafenib: A single-center experience
    MASATSUGU ENDO et al, 2016, Molecular and Clinical Oncology CrossRef
21. Early Relative Change in Hepatic Function with Lenvatinib for Unresectable Hepatocellular Carcinoma
    Atsushi Hiraoka et al, 2019, Oncology CrossRef
22. Laparoscopic Distal Pancreatectomy for Pancreatic Cancer
    Chang Moo Kang, 2017, Innovation of Diagnosis and Treatment for Pancreatic Cancer CrossRef
23. Sorafenib versus Transarterial chemoembolization for advanced-stage hepatocellular carcinoma: a cost-effectiveness analysis
    Shuling Chen et al, 2018, BMC Cancer CrossRef